Understanding the concept of health care-associated pneumonia in lung transplant recipients

Chest

Volumn 148, Issue 2, 2015, Pages 516-522

  Palacio, Federico ^a,b   Reyes, Luis F ^b,e   Levine, Deborah J ^a,b   Sanchez, Juan F ^c   Angel, Luis F ^b   Fernandez, Juan F ^b   Levine, Stephanie M ^b   Rello, Jordi ^d   Abedi, Ali ^b   Restrepo, Marcos I ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSIDAD DE LA SABANA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FIBROSING ALVEOLITIS; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INVASIVE ASPERGILLOSIS; LENGTH OF STAY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; RETROSPECTIVE STUDY; VENTILATOR ASSOCIATED PNEUMONIA; CHEMICALLY INDUCED; CROSS INFECTION; GRAFT REJECTION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; PNEUMONIA, VENTILATOR-ASSOCIATED;

ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES;

EID: 84939235335     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1948     Document Type: Article

References (20)

1. Chakinala MM, Trulock EP. Pneumonia in the solid organ transplant patient. Clin Chest Med. 2005; 26 (1): 113-121.
2. Yusen RD, Christie JD, Edwards LB, et al; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age. J Heart Lung Transplant. 2013; 32 (10): 965-978.
3. Speich R, van der Bij W. Epidemiology and management of infections aft er lung transplantation. Clin Infect Dis. 2001; 33 (suppl 1): S58-S65.
4. Gavald J, Román A. Infection in lung transplantation [in Spanish]. Enferm Infecc Microbiol Clin. 2007; 25 (10): 639-649.
5. Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis. 2001; 3 (3): 128-137.
6. Aguilar-Guisado M, Givaldá J, Ussetti P, et al; RESITRA cohort. Pneumonia after lung transplantation in the RESITRA cohort: a multicenter prospective study. Am J Transplant. 2007; 7 (8): 1989-1996.
7. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005; 128 (6): 3854-3862.
8. Carratal J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007; 167 (13): 1393-1399.
9. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171 (4): 388-416.
10. Stone RA, Obrosky DS, Singer DE, Kapoor WN, Fine MJ; Pneumonia Patient Outcomes Research Team (PORT) Investigators. Propensity score adjustment for pretreatment differences between hospitalized and ambulatory patients with community-acquired pneumonia. M ed Care. 1995; 33 (suppl 4): AS56-AS66.
11. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health careassociated pneumonia and communityacquired pneumonia: a single-center experience. A ntimicrob Agents Chemother. 2007; 51 (10): 3568-3573.
12. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH. Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest. 2008; 134 (5): 963-968.
13. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998; 157 (2): 531-539.
14. Campos S, Caramori M, Teixeira R, et al. Bacterial and fungal pneumonias aft er lung transplantation. Transplant Proc. 2008; 40 (3): 822-824.
15. Richards MJ, Edwards JR, Culver DH, Gaynes RP; National Nosocomial Infections Surveillance System. Nosocomial infections in medical intensive care units in the United States. Crit Care Med. 1999; 27 (5): 887-892.
16. Rello J, Luján M, Gallego M, et al; PROCORNEU Study Group. Why mortality is increased in health-careassociated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest. 2010; 137 (5): 1138-1144.
17. Lambotte O, Timsit JF, Garrouste-Orgeas M, Misset B, Benali A, Carlet J. The significance of distal bronchial samples with commensals in ventilatorassociated pneumonia: colonizer or pathogen? C hest. 2002; 122 (4): 1389-1399.
18. Hell W, Kern T, Klouche M. Staphylococcus saprophyticus as an unusual agent of nosocomial pneumonia. Clin Infect Dis. 1999; 29 (3): 685-686.
19. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev. 1994; 7 (1): 117-140.
20. Inai K, Iwasaki H, Noriki S, et al. Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies. Int J Hematol. 2007; 86 (3): 225-232.